Table 2 Comparison of primary patency between subgroups according to the clinical and lesion characteristics
Subgroup | N | Primary patency (%) | p value | Subgroup | N | Primary patency (%) | p value |
|---|---|---|---|---|---|---|---|
Female | 31 | 77.0 ± 9.0 | 0.217 | Claudication | 70 | 90.7 ± 4.0 | 0.008* |
Male | 84 | 83.9 ± 4.7 |  | CLIa | 45 | 66.0 ± 8.8 |  |
Hypertension | 83 | 80.7 ± 5.3 | 0.727 | Restenosis | 39 | 73.0 ± 7.8 | 0.099 |
No Hypertension | 32 | 80.6 ± 7.8 |  | De novo | 76 | 88.3 ± 4.5 |  |
Hyperlipidemia | 40 | 78.8 ± 7.9 | 0.998 | ISRb | 28 | 71.2 ± 9.2 | 0.238 |
No Hyperlipidemia | 75 | 81.5 ± 5.3 |  | Not ISR | 87 | 86.5 ± 4.5 |  |
Diabetes | 69 | 80.4 ± 5.6 | 0.560 | Moderate or severe calcification | 54 | 87.5 ± 5.3 | 0.105 |
No Diabetes | 46 | 84.6 ± 6.4 |  | No or mild calcification | 56 | 81.4 ± 6.4 |  |
Prior/Current Smoking | 52 | 81.2 ± 6.5 | 0.720 | Total occlusion | 90 | 78.0 ± 5.1 | 0.176 |
Nonsmoker | 63 | 82.7 ± 5.6 |  | Stenosis | 25 | 100.0 |  |
Coronary arterial disease | 30 | 78.9 ± 8.4 | 0.763 | Length > 200mm | 84 | 77.6 ± 5.8 | 0.123 |
No coronary arterial disease | 85 | 83.3 ± 4.9 |  | Length ≤ 200mm | 31 | 90.0 ± 5.5 |  |
History of stroke | 20 | 62.7 ± 12.1 | 0.173 | Bailout stent | 31 | 91.7 ± 5.6 | 0.291 |
No stroke | 95 | 86.6 ± 4.2 |  | No bailout stent | 84 | 78.3 ± 5.4 |  |
Renal failure | 8 | 50.0 ± 17.7 | 0.001* | TASCc D lesions | 33 | 67.5 ± 9.6 | 0.066 |
No renal failure | 107 | 85.7 ± 4.0 |  | TASC B/C lesions | 82 | 88.0 ± 4.3 |  |
With outflow | 75 | 92.8 ± 3.6 | 0.113 |  |  |  |  |
No outflow | 11 | 83.3 ± 15.2 |  |  |  |  |  |